Login to Your Account



Clinic Roundup


Wednesday, October 24, 2012

• Cytori Therapeutics Inc., of San Diego, said an investigator-sponsored trial has been cleared to start in France to study the company's cell therapy as a potential treatment for limited and diffuse cutaneous systemic sclerosis.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription